Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU.
Vigón L, García-Pérez J, Rodríguez-Mora S, Torres M, Mateos E, Castillo de la Osa M, Cervero M, Malo De Molina R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Alcamí J, Pérez-Olmeda M, Coiras M, López-Huertas MR. Vigón L, et al. Among authors: malo de molina r. Front Immunol. 2021 Sep 20;12:742631. doi: 10.3389/fimmu.2021.742631. eCollection 2021. Front Immunol. 2021. PMID: 34616404 Free PMC article.
Mild AST elevation as an early sign of COVID-19 severity in a multicenter Madrid cohort.
Fernández Carrillo C, Perelló C, Llop E, García-Samaniego J, Romero M, Mostaza JM, Ibáñez L, Bañares Cañizares R, Bighelli F, Usón Perón C, Fernández Vázquez I, Hernández Castro O, Lalueza A, Albillos A, Malo de Molina R, Múñez E, Jiménez Tejero E, Calleja JL. Fernández Carrillo C, et al. Among authors: malo de molina r. Rev Esp Enferm Dig. 2021 Nov;113(11):780-786. doi: 10.17235/reed.2021.8007/2021. Rev Esp Enferm Dig. 2021. PMID: 33947196 Free article.
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF; ConPlas-19 Study Group. Avendaño-Solá C, et al. Among authors: malo de molina r. J Clin Invest. 2021 Oct 15;131(20):e152740. doi: 10.1172/JCI152740. J Clin Invest. 2021. PMID: 34473652 Free PMC article. Clinical Trial.
Follow-up with Telemedicine in Early Discharge for COPD Exacerbations: Randomized Clinical Trial (TELEMEDCOPD-Trial).
Mínguez Clemente P, Pascual-Carrasco M, Mata Hernández C, Malo de Molina R, Arvelo LA, Cadavid B, López F, Sánchez-Madariaga R, Sam A, Trisan Alonso A, Valle Falcones M, Aguilar Pérez M, Muñoz A, Pérez de la Cámara S, Burgos A, López Viña A, Ussetti Gil P. Mínguez Clemente P, et al. Among authors: malo de molina r. COPD. 2021 Feb;18(1):62-69. doi: 10.1080/15412555.2020.1857717. Epub 2020 Dec 14. COPD. 2021. PMID: 33307857 Clinical Trial.
An international perspective on hospitalized patients with viral community-acquired pneumonia.
Radovanovic D, Sotgiu G, Jankovic M, Mahesh PA, Marcos PJ, Abdalla MI, Di Pasquale MF, Gramegna A, Terraneo S, Blasi F, Santus P, Aliberti S, Reyes LF, Restrepo MI; GLIMP Study Group. Radovanovic D, et al. Eur J Intern Med. 2019 Feb;60:54-70. doi: 10.1016/j.ejim.2018.10.020. Epub 2018 Nov 4. Eur J Intern Med. 2019. PMID: 30401576 Free PMC article.
Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
Puente-Maestu L, Calle M, Ortega-González A, Fuster A, González C, Márquez-Martín E, Marcos-Rodriguez PJ, Calero C, Rodríguez-Hermosa JL, Malo de Molina R, Aburto M, Sobradillo P, Alcázar B, Tirado-Conde G; GEMEPOC Group. Puente-Maestu L, et al. Among authors: malo de molina r. Respir Med. 2014 May;108(5):737-44. doi: 10.1016/j.rmed.2014.02.009. Epub 2014 Feb 20. Respir Med. 2014. PMID: 24635914 Free article.
Validation of the Spanish Version of the COPD-Q Questionnaire on COPD Knowledge.
Puente-Maestu L, Chancafe-Morgan J, Calle M, Rodríguez-Hermosa JL, Malo de Molina R, Ortega-González Á, Fuster A, Márquez-Martín E, Marcos PJ, Ramírez L, Ray S, Franks A; en nombre del grupo GemEPOC. Puente-Maestu L, et al. Among authors: malo de molina r. Arch Bronconeumol. 2016 Jan;52(1):12-6. doi: 10.1016/j.arbres.2015.03.013. Epub 2015 May 28. Arch Bronconeumol. 2016. PMID: 26026685 English, Spanish.
The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
García-Sidro P, Naval E, Martinez Rivera C, Bonnin-Vilaplana M, Garcia-Rivero JL, Herrejón A, Malo de Molina R, Marcos PJ, Mayoralas-Alises S, Ros JA, Valle M, Esquinas C, Barrecheguren M, Miravitlles M. García-Sidro P, et al. Among authors: malo de molina r. Respir Med. 2015 Dec;109(12):1546-52. doi: 10.1016/j.rmed.2015.10.011. Epub 2015 Oct 27. Respir Med. 2015. PMID: 26542727 Free article.
Risk Factors of Poor Outcomes after Admission for a COPD Exacerbation: Multivariate Logistic Predictive Models.
García-Rivero JL, Esquinas C, Barrecheguren M, Bonnin-Vilaplana M, García-Sidro P, Herrejón A, Martinez-Rivera C, Malo de Molina R, Marcos PJ, Mayoralas S, Naval E, Ros JA, Valle M, Miravitlles M. García-Rivero JL, et al. Among authors: malo de molina r. COPD. 2017 Apr;14(2):164-169. doi: 10.1080/15412555.2016.1260538. Epub 2016 Dec 16. COPD. 2017. PMID: 27983876
18 results